​

Stryker (SYK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SYK Stock Forecast

Stryker (SYK) stock forecast, based on 52 Wall Street analysts, predicts a 12-month average price target of $354.47, with a high of $407.00 and a low of $309.00. This represents a 15.53% increase from the last price of $306.81.

$250 $290 $330 $370 $410 $450 High: $407 Avg: $354.47 Low: $309 Last Closed Price: $306.81

SYK Stock Rating

Stryker stock's rating consensus is Buy, based on 52 Wall Street analysts. The breakdown includes 1 Strong Buy (1.92%), 35 Buy (67.31%), 16 Hold (30.77%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 52 16 35 1 Strong Sell Sell Hold Buy Strong Buy

SYK Price Target Upside V Benchmarks

TypeNameUpside
StockStryker15.53%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks16.23%

Price Target Trends

1M3M12M
# Anlaysts81244
Avg Price Target$336.50$339.33$381.61
Last Closing Price$306.81$306.81$306.81
Upside/Downside9.68%10.60%24.38%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 268157--30
Oct, 267156--28
Sep, 267156--28
Aug, 267165--28
Jul, 267146--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 02, 2026Rick WiseStifel Nicolaus$325.00$291.8611.35%5.93%
Oct 30, 2026Vik ChopraBMO Capital$309.00$296.004.39%0.71%
Oct 30, 2026Shagun SinghRBC Capital$375.00$295.0827.08%22.23%
Oct 30, 2026Jayson BedfordRaymond James$323.00$311.363.74%5.28%
Oct 30, 2026Mike MatsonNeedham$359.00$311.3615.30%17.01%
Oct 12, 2026Ryan ZimmermanBTIG$316.00$279.8312.93%3.00%
Oct 06, 2026Barclays$375.00$278.5034.65%22.23%
Oct 06, 2026Truist Financial$310.00$280.2310.62%1.04%
Sep 30, 2026Stifel Nicolaus$330.00$278.8618.34%7.56%
Sep 18, 2026Canaccord Genuity$385.00$280.1437.43%25.48%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 30, 2026BMO CapitalOutperformOutperformhold
Oct 30, 2026RBC CapitalOutperformOutperformhold
Oct 30, 2026Johnson RiceHolddowngrade
Oct 30, 2026Raymond JamesOutperformOutperformhold
Oct 30, 2026CitigroupMarket OutperformMarket Outperformhold
Oct 30, 2026NeedhamBuyBuyhold
Oct 12, 2026BTIGBuyBuyhold
Oct 07, 2026BernsteinMarket PerformMarket Performhold
Oct 06, 2026BarclaysOverweightOverweightinitialise
Oct 06, 2026NeedhamBuyBuyhold

Financial Forecast

EPS Forecast

$5 $9 $13 $17 $21 $25 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$5.29$6.23$8.34$7.86$8.49----
Avg Forecast$9.11$9.18$10.41$12.05$13.49$14.92$16.63$18.36$20.61
High Forecast$9.20$9.30$10.45$12.09$13.62$15.22$17.86$18.71$21.00
Low Forecast$8.97$9.05$10.37$12.02$13.28$14.60$15.65$18.00$20.20
Surprise %-41.93%-32.14%-19.88%-34.77%-37.06%----

Revenue Forecast

$15B $19B $23B $27B $31B $35B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$17.11B$18.45B$20.50B$22.59B$25.12B----
Avg Forecast$17.06B$18.21B$20.28B$22.52B$24.46B$26.37B$28.62B$31.09B$33.43B
High Forecast$17.18B$18.40B$20.41B$22.64B$24.75B$26.89B$28.69B$31.54B$33.92B
Low Forecast$16.86B$18.02B$20.23B$22.43B$24.17B$25.98B$28.54B$30.61B$32.91B
Surprise %0.29%1.32%1.05%0.32%2.69%----

Net Income Forecast

$2B $3B $4B $6B $7B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.99B$2.36B$3.17B$2.99B$3.25B----
Avg Forecast$1.98B$2.16B$3.17B$4.63B$5.16B$5.72B$6.43B$7.05B$7.91B
High Forecast$2.38B$2.59B$3.80B$4.64B$5.23B$5.84B$6.85B$7.18B$8.06B
Low Forecast$1.59B$1.73B$2.53B$4.61B$5.10B$5.60B$6.01B$6.91B$7.75B
Surprise %0.47%9.14%--35.32%-37.11%----

SYK Forecast FAQ

Is Stryker stock a buy?

Stryker stock has a consensus rating of Buy, based on 52 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 35 Buy, 16 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Stryker is a favorable investment for most analysts.

What is Stryker's price target?

Stryker's price target, set by 52 Wall Street analysts, averages $354.47 over the next 12 months. The price target range spans from $309 at the low end to $407 at the high end, suggesting a potential 15.53% change from the previous closing price of $306.81.

How does Stryker stock forecast compare to its benchmarks?

Stryker's stock forecast shows a 15.53% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (16.23%).

What is the breakdown of analyst ratings for Stryker over the past three months?

  • November 2026: 26.67% Strong Buy, 50.00% Buy, 23.33% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 25.00% Strong Buy, 53.57% Buy, 21.43% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 25.00% Strong Buy, 53.57% Buy, 21.43% Hold, 0% Sell, 0% Strong Sell.

What is Stryker’s EPS forecast?

Stryker's average annual EPS forecast for its fiscal year ending in December 2026 is $14.92, marking a 75.74% increase from the reported $8.49 in 2025. Estimates for the following years are $16.63 in 2027, $18.36 in 2028, and $20.61 in 2029.

What is Stryker’s revenue forecast?

Stryker's average annual revenue forecast for its fiscal year ending in December 2026 is $26.37B, reflecting a 5.01% increase from the reported $25.12B in 2025. The forecast for 2027 is $28.62B, followed by $31.09B for 2028, and $33.43B for 2029.

What is Stryker’s net income forecast?

Stryker's net income forecast for the fiscal year ending in December 2026 stands at $5.72B, representing an 76.26% increase from the reported $3.25B in 2025. Projections indicate $6.43B in 2027, $7.05B in 2028, and $7.91B in 2029.